FMC Lowers FY26 Adj EPS Guidance to $1.19-$1.49 Range
FMC Corporation cuts FY2026 adjusted EPS guidance to $1.19-$1.49 and sales to $3.5B-$3.7B, both falling below analyst estimates of $1.69 and $3.703B. The revisions reflect deteriorating operational outlooks for the agricultural science company.

*this image is generated using AI for illustrative purposes only.
FMC Corporation has significantly lowered its financial guidance for fiscal year 2026, signaling potential headwinds in its core operations. The company revised its adjusted earnings per share (EPS) estimate downward from a previous range of $1.63 to $1.89, setting a new target of $1.19 to $1.49. This updated figure falls well below the $1.69 analyst estimate, indicating a material shift in market expectations for the agricultural science firm.
Guidance Revision Details
The downward revision extends to top-line metrics as well. FMC reduced its sales guidance for FY2026 from $3.600 billion to $3.800 billion to a new range of $3.500 billion to $3.700 billion. This adjustment places the company’s outlook below the $3.703 billion analyst estimate, suggesting broader challenges in revenue generation across its portfolio.
| Metric | Previous Guidance | New Guidance | Analyst Estimate |
|---|---|---|---|
| Adj EPS | $1.63 - $1.89 | $1.19 - $1.49 | $1.69 |
| Sales | $3.600B - $3.800B | $3.500B - $3.700B | $3.703B |
What the Numbers Show
The divergence between the new guidance and analyst estimates highlights a significant negative surprise for investors. The midpoint of the new EPS guidance ($1.34) represents a substantial decline from the prior midpoint ($1.76), underscoring pressure on profitability. Similarly, the sales guidance cut suggests that volume or pricing dynamics may be weaker than previously anticipated, impacting the company’s ability to meet market consensus.
What specific operational or macroeconomic factors are driving the significant downward revision in FMC's FY2026 earnings and sales guidance?
How might this guidance cut impact FMC's stock valuation and investor sentiment in the near term compared to its agricultural science peers?
Is FMC planning to implement cost-cutting measures, strategic acquisitions, or portfolio adjustments to offset the projected revenue shortfall?
































